BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aguado J, Torre‐cisneros J, Fortún J, Benito N, Meije Y, Doblas A, Muñoz P. Tuberculosis in Solid‐Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. CLIN INFECT DIS 2009;48:1276-84. [DOI: 10.1086/597590] [Cited by in Crossref: 194] [Cited by in F6Publishing: 196] [Article Influence: 13.9] [Reference Citation Analysis]
Number Citing Articles
1 Katrak S, Han E, Readhead A, Fung M, Keh C, Flood J, Barry P. Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020. Am J Transplant 2022:S1600-6135(22)29290-9. [PMID: 36695700 DOI: 10.1016/j.ajt.2022.11.019] [Reference Citation Analysis]
2 Doblas A, Torre-Cisneros J. The role of alternative regimens in the management of tuberculosis in transplant recipients: From past challenges to future opportunities. Transpl Infect Dis 2022;24:e13958. [PMID: 36468202 DOI: 10.1111/tid.13958] [Reference Citation Analysis]
3 Radisic MV, Pujato NR, Bravo PM, Del Grosso RC, Hunter M, Beltramino S, Linares González L, Cornet ML, Del Carmen Rial M, Franzini RL, Dotta AC, León LR, Walther J, Uva PD, Werber G. Tuberculosis treatment without rifampin in kidney/kidney-pancreas transplantation: A case series report. Transpl Infect Dis 2022;24:e13949. [PMID: 36515463 DOI: 10.1111/tid.13949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ortiz-brizuela E, Menzies D, Behr MA. Testing and Treating Mycobacterium tuberculosis Infection. Medical Clinics of North America 2022;106:929-947. [DOI: 10.1016/j.mcna.2022.08.001] [Reference Citation Analysis]
5 Sorohan BM, Ismail G, Tacu D, Obrișcă B, Ciolan G, Gîngu C, Sinescu I, Baston C. Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive Review. Pathogens 2022;11:1041. [DOI: 10.3390/pathogens11091041] [Reference Citation Analysis]
6 Cooper R, Houston S, Hughes C, Johnston JC. Chapter 10: Treatment of active tuberculosis in special populations. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6:149-166. [DOI: 10.1080/24745332.2022.2039500] [Reference Citation Analysis]
7 Thirumalvalavan K, Surendran S, Anand S, Prasad NS, Fernando M. Tuberculosis in kidney transplant recipients: A retrospective study from a tertiary care center - An observational study. Indian J Transplant 2022;16:316. [DOI: 10.4103/ijot.ijot_33_22] [Reference Citation Analysis]
8 Chan G, Lynch B, Murray MA, Hannan MM. Opportunistic Bacterial, Fungal and Viral Infections in Lung Transplantation. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00259-6] [Reference Citation Analysis]
9 Rashid HU, Begum NAS, Kashem TS. Mycobacterial infections in solid organ transplant recipients. Korean J Transplant 2021;35:208-17. [DOI: 10.4285/kjt.21.0033] [Reference Citation Analysis]
10 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Lamm K, Jacobs C, Russo MW. A Case Series of Extrapulmonary Mycobacterium in Liver Transplant Recipients. ACG Case Rep J 2021;8:e00571. [PMID: 34549057 DOI: 10.14309/crj.0000000000000571] [Reference Citation Analysis]
12 Pyanzova TV, Basters ER, Zvereva TN, Galayda NM, Grigorieva EA. A case of Tuberculosis in the Patient after Orthotopic Heart Transplantation. Tuberk bolezni lëgk 2021;99:46-52. [DOI: 10.21292/2075-1230-2021-99-9-46-52] [Reference Citation Analysis]
13 Makanda-Charambira PD, Nourse P, Luyckx VA, Coetzee A, McCulloch MI. TB in paediatric kidney transplant recipients - A single-centre experience. Pediatr Transplant 2021;:e14141. [PMID: 34528349 DOI: 10.1111/petr.14141] [Reference Citation Analysis]
14 Kwon DE, Han SH, Han KD, La Y, Lee KH. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country. Transpl Infect Dis 2021;23:e13729. [PMID: 34505751 DOI: 10.1111/tid.13729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Slomovich S, Oh KT, Diakos NA, Restaino SW, Clerkin KJ, Latif F, Miyauchi JT, Lee A, Sayer GT, Uriel N. A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient. Transplant Proc 2021:S0041-1345(21)00508-X. [PMID: 34399971 DOI: 10.1016/j.transproceed.2021.07.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nasir N, Sarfaraz S, Khanum I, Ansari T, Nasim A, Dodani SK, Luxmi S. Tuberculosis in Solid Organ Transplantation: Insights from TB Endemic Areas. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00756-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Malinis M, Koff A. Mycobacterium tuberculosis in solid organ transplant donors and recipients. Curr Opin Organ Transplant 2021;26:432-9. [PMID: 34074939 DOI: 10.1097/MOT.0000000000000885] [Reference Citation Analysis]
18 Meinerz G, Silva CKD, Dorsdt DMB, Adames JB, Andrade JP, Ventura PE, Monteiro AA, Pasqualotto AC, Garcia VD, Keitel E. Latent tuberculosis screening before kidney transplantation in the South of Brazil. J Bras Nefrol 2021;43:520-9. [PMID: 33999988 DOI: 10.1590/2175-8239-JBN-2020-0189] [Reference Citation Analysis]
19 Runyo F, Matignon M, Audureau E, Vindrios W, Boueilh A, Gomart C, Grimbert P, Gallien S, Melica G. Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study. Transpl Infect Dis 2021;:e13607. [PMID: 33773002 DOI: 10.1111/tid.13607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Thitisuriyarax S, Vanichanan J, Udomkarnjananun S, Townamchai N, Jutivorakool K. Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country. Transpl Infect Dis 2021;23:e13566. [PMID: 33428318 DOI: 10.1111/tid.13566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Dubois M, Dixit A, Lamb G. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients. Glob Pediatr Health 2021;8:2333794X20981548. [PMID: 33506075 DOI: 10.1177/2333794X20981548] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Pellett Madan R, Danziger-isakov LA. Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant. Pediatric Transplant and Oncology Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-64198-2.00013-0] [Reference Citation Analysis]
23 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_15] [Reference Citation Analysis]
24 Munoz FM, Ling Lin P. Nontuberculous and tuberculous Mycobacterium. Pediatric Transplant and Oncology Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-64198-2.00025-7] [Reference Citation Analysis]
25 Riccardi N, Villa S, Canetti D, Giacomelli A, Taramasso L, Martini M, Di Biagio A, Bragazzi NL, Brigo F, Sotgiu G, Besozzi G, Codecasa L. Missed opportunities in tb clinical practice: How to bend the curve? A medical, social, economic and ethical point of view. Tuberculosis (Edinb) 2021;126:102041. [PMID: 33385833 DOI: 10.1016/j.tube.2020.102041] [Reference Citation Analysis]
26 Wang Y, Salvador NG, Lin C, Wu C, Lin T, Lee W, Chan Y, Chen C, Co JS, Encarnacion DD. Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis. Biomedical Journal 2020. [DOI: 10.1016/j.bj.2020.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Solé A, Part-lopez M, Saez B, Laporta R, Anguera G, Cuesta VM, De Pablo A, Canyada-martinez AJ, Pastor A, Gil A, Caminero JA, Bravo C. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin. Archivos de Bronconeumología 2020;56:493-8. [DOI: 10.1016/j.arbres.2019.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Solé A, Part-lopez M, Saez B, Laporta R, Anguera G, Cuesta VM, De Pablo A, Canyada-martinez AJ, Pastor A, Gil A, Caminero JA, Bravo C. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin. Archivos de Bronconeumología (English Edition) 2020;56:493-498. [DOI: 10.1016/j.arbr.2019.10.017] [Reference Citation Analysis]
29 Basic-Jukic N, Juric I, Furic-Cunko V, Kastelan Z. Central nervous system infections in renal transplant recipients. Transpl Infect Dis 2020;22:e13341. [PMID: 32453874 DOI: 10.1111/tid.13341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
30 Bavaro DF, Fiordelisi D, Angarano G, Monno L, Saracino A. Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections. Expert Opin Drug Saf 2020;19:817-42. [PMID: 32394759 DOI: 10.1080/14740338.2020.1767585] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
31 Prieto LM, Santiago B, Del Rosal T, Carazo B, Jiménez AB, Pérez-Gorricho B, Rubio F, Tagarro A, Blázquez-Gamero D, Moreno-Pérez D, Mellado MJ, Baquero-Artigao F; Spanish Paediatric TB Research Network (pTBred). Linezolid-containing Treatment Regimens for Tuberculosis in Children. Pediatr Infect Dis J 2019;38:263-7. [PMID: 29750764 DOI: 10.1097/INF.0000000000002093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
32 Len O, Los-Arcos I, Aguado JM, Blanes M, Bodro M, Carratalà J, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Gavaldà J, López-Medrano F, López-Vélez R, Lumbreras C, Mahillo B, Marcos MÁ, Martin-Dávila P, Montejo JM, Moreno A, Muñoz P, Norman F, Pérez-Sáenz JL, Pumarola T, Sabé N, San-Juan R, Vidal E, Domínguez-Gil B; Grupo de Estudio de la Infección en el Trasplante (GESITRA) of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) and the Organización Nacional de Trasplantes (ONT). Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus. Transplant Rev (Orlando) 2020;34:100528. [PMID: 32001103 DOI: 10.1016/j.trre.2020.100528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Berger GN, Pagalilauan GL. Infections in the Adult Solid Organ Transplant Recipient. Primary Care of the Solid Organ Transplant Recipient 2020. [DOI: 10.1007/978-3-030-50629-2_8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_15-1] [Reference Citation Analysis]
35 Abad CL, Razonable RR. Prevention and treatment of tuberculosis in solid organ transplant recipients. Expert Rev Anti Infect Ther 2020;18:63-73. [PMID: 31826668 DOI: 10.1080/14787210.2020.1704255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
36 Alrajhi AA, Alotaibi J, Alghamdi AM, Almanea H, Alsebayel M, Al‐meshari K, Al‐hajoj S. Mycobacterium tuberculosis DNA in living donor transplanted livers and donor‐related tuberculosis in recipients: A retrospective longitudinal cohort study. Transpl Infect Dis 2019;22. [DOI: 10.1111/tid.13212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
37 Sarıbeyliler G, Alimoğlu SS, Mirioğlu Ş, Demir E, Çağatay A, Yazıcı H. Tuberculosis Mastitis: Fever of Unknown Origin in a Kidney Transplant Recipient. Eur J Breast Health 2019;15:272-4. [PMID: 31620688 DOI: 10.5152/ejbh.2019.4488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Leong LY, Lin PC, Chi CY, Chou CH, Lu MC, Liao WC, Ho MW, Wang JH, Jeng LB. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect 2021;54:312-8. [PMID: 31668794 DOI: 10.1016/j.jmii.2019.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Abad CLR, Deziel PJ, Razonable RR. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl Infect Dis 2019;21:e13178. [PMID: 31541575 DOI: 10.1111/tid.13178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
40 Schmidt-Lauber C, Jacobi J, Polifka I, Hilgers KF, Wiesener MS. Suspected colonic cancer turns out to be disseminated tuberculosis in a kidney transplant recipient: A case report. Medicine (Baltimore) 2019;98:e16995. [PMID: 31490381 DOI: 10.1097/MD.0000000000016995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Anastasopoulou A, Ziogas DC, Samarkos M, Kirkwood JM, Gogas H. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations. J Immunother Cancer 2019;7:239. [PMID: 31484550 DOI: 10.1186/s40425-019-0717-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
42 Rafiei N, Williams J, Mulley WR, Trauer JM, Jenkin GA, Rogers BA. Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort. Nephrology (Carlton) 2019;24:569-74. [PMID: 29660203 DOI: 10.1111/nep.13386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
43 Fishman JA. Mycobacterium tuberculosis in transplantation: Immunity sufficient to perpetuate disease? Am J Transplant 2019;19:1262-3. [PMID: 30614189 DOI: 10.1111/ajt.15254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Malinis M, Boucher HW; on behalf of the AST Infectious Diseases Community of Practice. Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13548] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
45 Subramanian AK, Theodoropoulos NM; Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant 2019;33:e13513. [PMID: 30817030 DOI: 10.1111/ctr.13513] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
46 Krishnamoorthy S, Kumaresan N, Zumla A. Latent tuberculosis infection and renal transplantation – Diagnosis and management. International Journal of Infectious Diseases 2019;80:S73-6. [DOI: 10.1016/j.ijid.2019.01.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
47 Nasiri MJ, Pormohammad A, Goudarzi H, Mardani M, Zamani S, Migliori GB, Sotgiu G. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA. Infection 2019;47:353-61. [PMID: 30805899 DOI: 10.1007/s15010-019-01285-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
48 Ertuğrul G, Düger M. Prophylaxis for latent tuberculosis infection in liver transplant recipients. Journal of Surgery and Medicine 2019. [DOI: 10.28982/josam.527957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Altshuler J, Aitken SL, Maslow M, Papadopoulos J, Safdar A. Antibiotic Consideration in Transplant Recipients. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_50] [Reference Citation Analysis]
50 Portal-celhay C, Philips JA. Tuberculosis. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Fishman JA, Costa SF, Alexander BD. Infection in Kidney Transplant Recipients. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00031-0] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Cahuayme-Zuniga LJ, Brust KB. Mycobacterial Infections in Patients With Chronic Kidney Disease and Kidney Transplantation. Adv Chronic Kidney Dis 2019;26:35-40. [PMID: 30876615 DOI: 10.1053/j.ackd.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
53 Philley JV, Griffith DE. Antimycobacterial Consideration in Transplantation Including Drug Non-susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_56] [Reference Citation Analysis]
54 Kowada A. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective. Journal of Infection 2019;78:58-65. [DOI: 10.1016/j.jinf.2018.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
55 Meije Y, Kwak EJ, Aguado JM. Prevention and Treatment of Mycobacterial Infections. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_14] [Reference Citation Analysis]
56 Marriott DJ, Orla Morrissey C. Common Infections Following Lung Transplantation. Essentials in Lung Transplantation 2019. [DOI: 10.1007/978-3-319-90933-2_15] [Reference Citation Analysis]
57 Muñoz P, Stosor T. Management of CNS Infections. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_17] [Reference Citation Analysis]
58 Bosch A, Valour F, Dumitrescu O, Dumortier J, Radenne S, Pages-Ecochard M, Chidiac C, Ferry T, Perpoint T, Miailhes P, Conrad A, Goutelle S, Ader F; Lyon TB study Group. A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area. Med Mal Infect. 2019;49:231-240. [PMID: 30591271 DOI: 10.1016/j.medmal.2018.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Santoro-Lopes G, Subramanian AK, Molina I, Aguado JM, Rabagliatti R, Len O. Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018;102:S60-S65. [PMID: 29381579 DOI: 10.1097/tp.0000000000002014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
60 Salvador NGA, Wee SY, Lin CC, Wu CC, Lu HI, Lin TL, Lee WF, Chan YC, Lin LM, Chen CL. Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation. Ann Transplant 2018;23:733-43. [PMID: 30337516 DOI: 10.12659/AOT.911034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
61 Rahimifard N, Mahmoudi S, Mamishi S, Pourakbari B. Prevalence of latent tuberculosis infection in transplant candidates: A systematic review and meta-analysis. Microb Pathog 2018;125:401-10. [PMID: 30291870 DOI: 10.1016/j.micpath.2018.09.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
62 Henry B, Bourgarit A. [Interferon gamma release assay tests for the diagnosis of latent and active tuberculosis in hemodialysis patients or solid organ transplant recipients]. Rev Mal Respir 2018;35:890-3. [PMID: 30268409 DOI: 10.1016/j.rmr.2018.08.015] [Reference Citation Analysis]
63 Qiu J, Liu S, Wang Q. Treatment of tuberculosis infection complicated with liver transplant. Infection International 2018;7:81-7. [DOI: 10.2478/ii-2018-0025] [Reference Citation Analysis]
64 Hasan T, Au E, Chen S, Tong A, Wong G. Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines. BMJ Open 2018;8:e022445. [PMID: 30209157 DOI: 10.1136/bmjopen-2018-022445] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
65 Nosotti M, Tarsia P, Morlacchi LC. Infections after lung transplantation. J Thorac Dis 2018;10:3849-68. [PMID: 30069386 DOI: 10.21037/jtd.2018.05.204] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 8.4] [Reference Citation Analysis]
66 Machuca I, Vidal E, de la Torre-cisneros J, Rivero-román A. Tuberculosis in immunosuppressed patients. Enfermedades infecciosas y microbiologia clinica (English ed ) 2018;36:366-374. [DOI: 10.1016/j.eimce.2018.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
67 Abad CLR, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases. Clin Transplant. 2018;32:e13259. [PMID: 29656530 DOI: 10.1111/ctr.13259] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
68 Pennington KM, Kennedy CC, Chandra S, Lauzardo M, Brito MO, Griffith DE, Seaworth BJ, Escalante P. Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review. J Clin Tuberc Other Mycobact Dis 2018;11:37-46. [PMID: 31720390 DOI: 10.1016/j.jctube.2018.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
69 Cobelens F, Nagelkerke N, Fletcher H. The convergent epidemiology of tuberculosis and human cytomegalovirus infection. F1000Res 2018;7:280. [PMID: 29780582 DOI: 10.12688/f1000research.14184.2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
70 Cobelens F, Nagelkerke N, Fletcher H. The convergent epidemiology of tuberculosis and human cytomegalovirus infection. F1000Res 2018;7:280. [DOI: 10.12688/f1000research.14184.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
71 Hand J, Sigel K, Huprikar S, Hamula C, Rana M. Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON® -TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant. Transpl Infect Dis 2018;20:e12845. [PMID: 29359834 DOI: 10.1111/tid.12845] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
72 Sayyahfar S, Davoodzadeh F, Hoseini R, Rahimzadeh N, Otukesh H. Comparison of tuberculin skin test and interferon gamma release assay for diagnosis of latent tuberculosis infection in pediatric candidates of renal transplantation. Pediatr Transplant 2018;22. [PMID: 29388291 DOI: 10.1111/petr.13148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
73 Fagiolino P, Vázquez M, Ibarra M, Maldonado C, Eiraldi R. Drug-Drug and Food-Drug Interactions of Pharmacokinetic Nature. ADME Processes in Pharmaceutical Sciences 2018. [DOI: 10.1007/978-3-319-99593-9_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
74 Namdar R, Peloquin CA. Drugs for Tuberculosis. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions 2018. [DOI: 10.1007/978-3-319-72416-4_6] [Reference Citation Analysis]
75 Machuca I, Vidal E, de la Torre-Cisneros J, Rivero-Román A. Tuberculosis in immunosuppressed patients. Enferm Infecc Microbiol Clin (Engl Ed) 2018;36:366-74. [PMID: 29223319 DOI: 10.1016/j.eimc.2017.10.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
76 Lee SJ, Kim KH, Hong SK, Hankins S. Evaluation of a Heart Transplant Candidate. Curr Cardiol Rep 2017;19:133. [PMID: 29103157 DOI: 10.1007/s11886-017-0934-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
77 Pena T, Klesney-Tait J. Mycobacterial Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:761-70. [PMID: 29128024 DOI: 10.1016/j.ccm.2017.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
78 Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 2017;101:S1-S109. [PMID: 28742762 DOI: 10.1097/TP.0000000000001769] [Cited by in Crossref: 108] [Cited by in F6Publishing: 175] [Article Influence: 18.0] [Reference Citation Analysis]
79 Yeo HJ, Cho WH, Kim D, Jeon D, Kim YS. Successful Single-Lung Transplantation in a Patient With a Lung Destroyed by Tuberculosis. Ann Thorac Surg 2017;103:e397-9. [PMID: 28431709 DOI: 10.1016/j.athoracsur.2016.09.095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
80 Aguado JM, Silva JT, Samanta P, Singh N. Tuberculosis and Transplantation. Microbiol Spectr. 2016;4. [PMID: 27809952 DOI: 10.1128/microbiolspec.tnmi7-0005-2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
81 Al-mukhaini SM, Al-eid H, Alduraibi F, Hakami HI, Al Talhi H, Shoukri M, Ahmed AM, Ahmed Y, Alrajhi AA. Mycobacterium Tuberculosis in Solid Organ Transplantation: Incidence before and after Expanded Isoniazid Prophylaxis. Ann Saudi Med 2017;37:138-43. [DOI: 10.5144/0256-4947.2017.138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
82 Anand M, Nayyar E, Concepcion B, Salani M, Schaefer H. Tuberculosis in kidney transplant recipients: A case series. World J Transplant 2017; 7(3): 213-221 [PMID: 28698838 DOI: 10.5500/wjt.v7.i3.213] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
83 Lum LHW, Chen FW, Jackett L, Strasser SI, Davis RJ. Fever and Pancytopenia in a Liver Transplant Recipient: Going Against the Rules of Occam's Razor. Transplant Direct 2017;3:e169. [PMID: 28706972 DOI: 10.1097/TXD.0000000000000691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Moon HH, Park SY, Kim JM, Park JB, Kwon CHD, Peck KR, Kim SJ, Lee SK, Joh JW. Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area. Ann Transplant. 2017;22:338-345. [PMID: 28579606 DOI: 10.12659/aot.902989] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
85 Levitt DL, Mesmar B, Munir KM. Renal Transplant-Associated Thyroid Tuberculosis. J Endocr Soc 2017;1:553-9. [PMID: 29264509 DOI: 10.1210/js.2016-1058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Aguado JM, Tiago Silva J, Samanta P, Singh N. Tuberculosis and Transplantation. Tuberculosis and Nontuberculous Mycobacterial Infections 2017. [DOI: 10.1128/9781555819866.ch36] [Reference Citation Analysis]
87 Cassir N, Delacroix R, Gomez C, Secq V, Reynaud-Gaubert M, Thomas PA, Papazian L, Drancourt M. Transplanted lungs and the "white plague": A case-report and review of the literature. Medicine (Baltimore) 2017;96:e6173. [PMID: 28353558 DOI: 10.1097/MD.0000000000006173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
88 Iglesias J, Ledesma KJ, Couto PJ, Liu J. Immune Reconstitution Inflammatory Syndrome Occurring in a Kidney Transplant Patient with Extrapulmonary Tuberculosis. Case Rep Transplant 2017;2017:6290987. [PMID: 28367350 DOI: 10.1155/2017/6290987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
89 Guirao-arrabal E, Santos F, Redel J, Vaquero JM, Torre-cisneros J. Efficacy and safety of short-term treatment with isoniazid and rifampicin for latent tuberculosis infection in lung transplant candidates. Clin Transplant 2017;31:e12901. [DOI: 10.1111/ctr.12901] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
90 Muñoz P, Giannella M, Bouza E. Heart, Lung and Heart–Lung Transplantation. Infectious Diseases 2017. [DOI: 10.1016/b978-0-7020-6285-8.00081-2] [Reference Citation Analysis]
91 Arze S, Arze L, Abecia C. Post-transplantation Infections in Bolivia. Transplant Proc 2016;48:646-53. [PMID: 27110022 DOI: 10.1016/j.transproceed.2016.02.049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
92 Jensen T, Darley D, Goeman E, Shaw K, Marriott D, Glanville A. Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection. Transpl Infect Dis 2016;18:782-4. [DOI: 10.1111/tid.12580] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
93 Muñoz L, Santin M. Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice. Transplantation 2016;100:1840-52. [DOI: 10.1097/tp.0000000000001224] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
94 Simner PJ, Woods GL, Wengenack NL, Hayden RT, Wolk DM, Carroll KC, Tang Y. Mycobacteria. Microbiol Spectr 2016;4. [DOI: 10.1128/microbiolspec.dmih2-0016-2015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016;63:e147-95. [PMID: 27516382 DOI: 10.1093/cid/ciw376] [Cited by in Crossref: 582] [Cited by in F6Publishing: 626] [Article Influence: 83.1] [Reference Citation Analysis]
96 Guirao-Arrabal E, Santos F, Redel-Montero J, Vaquero JM, Cantisán S, Vidal E, Torre-Giménez Á, Rivero A, Torre-Cisneros J. Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use. Transpl Infect Dis 2016;18:512-9. [PMID: 27224905 DOI: 10.1111/tid.12555] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
97 Fernández-ruiz M, Silva J, López-medrano F, Allende L, San Juan R, Cambra F, Justo I, Paz-artal E, Jiménez C, Aguado J. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients. Transpl Infect Dis 2016;18:552-65. [DOI: 10.1111/tid.12564] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
98 Marmor R, Logan C, Hemming A, Berumen J. Fever, Cough, and Right Lower Quadrant Abdominal Pain in a Liver Transplant Recipient. Am J Transplant 2016;16:1933-5. [DOI: 10.1111/ajt.13772] [Reference Citation Analysis]
99 Simner PJ, Woods GL, Wengenack NL. Mycobacteria. Diagnostic Microbiology of the Immunocompromised Host 2016. [DOI: 10.1128/9781555819040.ch16] [Reference Citation Analysis]
100 Chellappan A, Kushwaha R, Lal H, Prasad R, Yadav P, Kumar A, Gupta A. Isolated empyema necessitans in a renal transplant recipient: A case report. Indian Journal of Transplantation 2016;10:46-48. [DOI: 10.1016/j.ijt.2016.04.001] [Reference Citation Analysis]
101 Meinerz G, da Silva C, Goldani J, Garcia V, Keitel E. Epidemiology of tuberculosis after kidney transplantation in a developing country. Transpl Infect Dis 2016;18:176-82. [DOI: 10.1111/tid.12501] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
102 Dan JM, Crespo M, Silveira FP, Kaplan R, Aslam S. Mycobacterium bovis hip bursitis in a lung transplant recipient. Transpl Infect Dis 2016;18:120-4. [PMID: 26671334 DOI: 10.1111/tid.12491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Sauzullo I, Vullo V, Mastroianni CM. Detecting latent tuberculosis in compromised patients. Curr Opin Infect Dis 2015;28:275-82. [PMID: 25887610 DOI: 10.1097/QCO.0000000000000158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
104 Ali HA, Palmer SM, Manuel O. Special Considerations for Long-Term Survivors After Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_53] [Reference Citation Analysis]
105 Larson AM, Mcdonald GB. Hepatobiliary Infections After Solid Organ or Hematopoietic Cell Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_36] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
106 Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM; ESCMID Study Group of Infection in Compromised Hosts. Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:89-101. [PMID: 24707957 DOI: 10.1111/1469-0691.12641] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
107 Schultz V, Marroni CA, Amorim CS, Baethgen LF, Pasqualotto AC. Risk factors for hepatotoxicity in solid organ transplants recipients being treated for tuberculosis. Transplant Proc. 2014;46:3606-3610. [PMID: 25498098 DOI: 10.1016/j.transproceed.2014.09.148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
108 Pierrotti LC, Kotton CN. Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases. Curr Infect Dis Rep 2015;17:492. [PMID: 26031964 DOI: 10.1007/s11908-015-0492-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
109 Benito N, García-Vázquez E, Horcajada JP, González J, Oppenheimer F, Cofán F, Ricart MJ, Rimola A, Navasa M, Rovira M, Roig E, Pérez-Villa F, Cervera C, Moreno A. Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect 2015;21:651-8. [PMID: 25882369 DOI: 10.1016/j.cmi.2015.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
110 Bagheri Amiri F, Saifi M, Gouya MM, Rohani M, Mostafavi E. Comparison of an interferon-gamma release assay and the tuberculin skin test for diagnosis of latent tuberculosis in homeless people in Iran: a cross-sectional study. Infect Dis (Lond) 2015;47:536-41. [PMID: 25832455 DOI: 10.3109/23744235.2015.1026934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
111 Muñoz L, Gomila A, Casas S, Castellote J, Arnan M, Rafecas A, Santin M. Immunodiagnostic Tests' Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study. Transplant Direct 2015;1:e12. [PMID: 27500217 DOI: 10.1097/TXD.0000000000000520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
112 Kim SH, Kim MY, Hong SI, Jung J, Lee HJ, Yun SC, Lee SO, Choi SH, Kim YS, Woo JH. Invasive Pulmonary Aspergillosis-mimicking Tuberculosis. Clin Infect Dis 2015;61:9-17. [PMID: 25778752 DOI: 10.1093/cid/civ216] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
113 Rathi S, Dhiman RK. Hepatobiliary quiz (answers)-13 (2015). J Clin Exp Hepatol 2015;5:100-4. [PMID: 25941440 DOI: 10.1016/j.jceh.2015.03.002] [Reference Citation Analysis]
114 Torre-Cisneros J, San-Juan R, Rosso-Fernández CM, Silva JT, Muñoz-Sanz A, Muñoz P, Miguez E, Martín-Dávila P, López-Ruz MA, Vidal E, Cordero E, Montejo M, Blanes M, Fariñas MC, Herrero JI, Rodrigo J, Aguado JM. Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial. Clin Infect Dis 2015;60:1642-9. [PMID: 25722196 DOI: 10.1093/cid/civ156] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
115 Bekaoui S, Haddiya I, El Housni S, ElHarraqui R, Rhou H, Benamar L, Eziatouni F, Ouzeddoun N, Bayahia R. [Spinal tuberculosis in renal transplant complicated by systemic fungal infection]. Pan Afr Med J 2014;19:22. [PMID: 25667684 DOI: 10.11604/pamj.2014.19.22.2878] [Reference Citation Analysis]
116 Sidhu A, Verma G, Humar A, Kumar D. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation. 2014;98:671-675. [PMID: 24825525 DOI: 10.1097/tp.0000000000000133] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
117 Sun H. Treating tuberculosis in solid organ transplant recipients. Current Opinion in Infectious Diseases 2014;27:501-5. [DOI: 10.1097/qco.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
118 Choi YM, Wu JJ. Reviewing the Guidelines for Tuberculosis Screening in Psoriasis Patients Treated with Biologics. Psoriasis Forum 2014;20a:163-169. [DOI: 10.1177/247553031420a00408] [Reference Citation Analysis]
119 Pedersen M, Seetharam A. Infections after orthotopic liver transplantation. J Clin Exp Hepatol 2014;4:347-60. [PMID: 25755581 DOI: 10.1016/j.jceh.2014.07.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
120 Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, Grossi P. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor–derived infections. Clinical Microbiology and Infection 2014;20:10-8. [DOI: 10.1111/1469-0691.12557] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
121 Miro J, Agüero F, Duclos-vallée J, Mueller N, Grossi P, Moreno A. Infections in solid organ transplant HIV-infected patients. Clinical Microbiology and Infection 2014;20:119-30. [DOI: 10.1111/1469-0691.12754] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
122 Subramanian AK. Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Current Opinion in Infectious Diseases 2014;27:316-21. [DOI: 10.1097/qco.0000000000000082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
123 Olithselvan A, Rajagopala S, Vij M, Shanmugam V, Shanmugam N, Rela M. Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center. Liver Transpl 2014;20:960-6. [PMID: 24789170 DOI: 10.1002/lt.23903] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
124 Liu J, Yan J, Wan Q, Ye Q, Huang Y. The risk factors for tuberculosis in liver or kidney transplant recipients. BMC Infect Dis 2014;14:387. [PMID: 25015108 DOI: 10.1186/1471-2334-14-387] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
125 Fernández-Ruiz M, Humar A, Kumar D. Latent tuberculosis infection: is universal screening the right approach? Am J Transplant 2014;14:1707-8. [PMID: 24888397 DOI: 10.1111/ajt.12793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
126 Speth F, Wellinghausen N, Haas JP. [Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2]. Z Rheumatol 2013;72:896-909. [PMID: 23929242 DOI: 10.1007/s00393-013-1203-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
127 Herrero Martínez J, Hernández Torres A, García Vázquez E, Gómez Gómez J. Protocolo diagnóstico del paciente inmunosuprimido sin infección por el VIH y fiebre. Medicine - Programa de Formación Médica Continuada Acreditado 2014;11:3452-3456. [DOI: 10.1016/s0304-5412(14)70799-1] [Reference Citation Analysis]
128 Herrero Martínez J, Hernández Torres A, García Vázquez E, Gómez Gómez J. Protocolo terapéutico del paciente inmunosuprimido sin infección por el VIH y fiebre. Medicine - Programa de Formación Médica Continuada Acreditado 2014;11:3457-3461. [DOI: 10.1016/s0304-5412(14)70800-5] [Reference Citation Analysis]
129 Maynard-Smith L, Fernando B, Hopkins S, Harber M, Lipman M. Managing latent tuberculosis in UK renal transplant units: how does practice compare with published guidance? Clin Med (Lond) 2014;14:26-9. [PMID: 24532739 DOI: 10.7861/clinmedicine.14-1-26] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
130 Fagiuoli S, Colli A, Bruno R, Craxì A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P, Burra P; 2011 AISF Single Topic Group. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol 2014;60:1075-89. [PMID: 24384327 DOI: 10.1016/j.jhep.2013.12.021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
131 de Castilla DL, Rakita RM, Spitters CE, Narita M, Jain R, Limaye AP. Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates. Transplantation. 2014;97:206-211. [PMID: 24142036 DOI: 10.1097/tp.0b013e3182a94a2f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
132 Marcos Sánchez F, Blanco Jarava A, Yzusqui Mendoza M, Vizuete Calero A, Magallanes Gamboa J. Tuberculosis. Medicine - Programa de Formación Médica Continuada Acreditado 2014;11:3054-3062. [DOI: 10.1016/s0304-5412(14)70739-5] [Reference Citation Analysis]
133 Adamu B, Abdu A, Abba AA, Borodo MM, Tleyjeh IM. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis. Cochrane Database Syst Rev 2014;:CD008597. [PMID: 24590589 DOI: 10.1002/14651858.CD008597.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
134 Mortensen E, Hellinger W, Keller C, Cowan LS, Shaw T, Hwang S, Pegues D, Ahmedov S, Salfinger M, Bower WA. Three cases of donor-derived pulmonary tuberculosis in lung transplant recipients and review of 12 previously reported cases: opportunities for early diagnosis and prevention. Transpl Infect Dis 2014;16:67-75. [PMID: 24383414 DOI: 10.1111/tid.12171] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
135 Regmi A, Singh P, Harford A. A Case of Multidrug-Resistant Monoarticular Joint Tuberculosis in a Renal Transplant Recipient. Transplantation Proceedings 2014;46:274-7. [DOI: 10.1016/j.transproceed.2013.07.071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
136 Munoz L, Santin M. Interferon-  Release Assays in Solid Organ Transplant Recipients: Everything Begins With a Single Small Step. Clinical Infectious Diseases 2014;58:904-5. [DOI: 10.1093/cid/cit923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
137 de Lemos AS, Vieira MA, Halpern M, Quaresma RG, Borchardt AC, Santos MA, Gonçalves RT, Santoro-Lopes G. Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area. Am J Transplant 2013;13:3230-5. [PMID: 24119248 DOI: 10.1111/ajt.12470] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
138 Ramos JF, Batista MV, Costa SF. Tuberculosis in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis 2013;5:e2013061. [PMID: 24363876 DOI: 10.4084/MJHID.2013.061] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
139 Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis. 2013;57:1473-1482. [PMID: 23899676 DOI: 10.1093/cid/cit488] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
140 Coll E, Torre-cisneros J, Calvo R, Garrido G, Matesanz R. Incidence of Tuberculosis in Deceased-Organ Donors and Transmission Risk to Recipients in Spain. Transplantation 2013;96:205-10. [DOI: 10.1097/tp.0b013e3182977adf] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
141 Hadaya K, Bridevaux P, Roux-lombard P, Delort A, Saudan P, Martin P, Janssens J. Contribution of Interferon-γ Release Assays (IGRAs) to the Diagnosis of Latent Tuberculosis Infection After Renal Transplantation. Transplantation 2013;95:1485-90. [DOI: 10.1097/tp.0b013e3182907073] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
142 Geramizadeh B, Nikeghbalian S, Janghorban P, Malekhosseini SA. Isolated tuberculosis of transplanted liver, a case report and review of the literature. Hepat Mon 2013;13:e6691. [PMID: 23914226 DOI: 10.5812/hepatmon.6691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
143 Boillat-Blanco N, Aguado JM, Aubert JD, Sester M, Grossi P, Kamar N, Pascual M, Manuel O; ESCMID Study Group of Infection in Compromised Hosts. European survey on the management of tuberculosis in solid-organ transplant recipients and candidates. Transpl Int. 2013;26:e69-e70. [PMID: 23582103 DOI: 10.1111/tri.12102] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
144 Küpeli E, Eyüboğlu FÖ, Haberal M. Pulmonary infections in transplant recipients. Curr Opin Pulm Med 2012;18:202-12. [PMID: 22388586 DOI: 10.1097/MCP.0b013e328352104f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
145 Fischer SA, Lu K; AST Infectious Diseases Community of Practice. Screening of donor and recipient in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:9-21. [PMID: 23464994 DOI: 10.1111/ajt.12094] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 9.8] [Reference Citation Analysis]
146 Subramanian AK, Morris MI; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:68-76. [PMID: 23465000 DOI: 10.1111/ajt.12100] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 12.9] [Reference Citation Analysis]
147 Marques IDB, Azevedo LS, Pierrotti LC, Caires RA, Sato VAH, Carmo LPF, Ferreira GF, Gamba C, de Paula FJ, Nahas WC, David-neto E. Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade. Clin Transplant 2013;27:E169-76. [DOI: 10.1111/ctr.12077] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
148 Verma S, Kaplowitz N. Hepatotoxicity of Antitubercular Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 483-504. [DOI: 10.1016/b978-0-12-387817-5.00027-3] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
149 Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, Teperman LW. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:3-26. [PMID: 23281277 DOI: 10.1002/lt.23566] [Cited by in Crossref: 321] [Cited by in F6Publishing: 274] [Article Influence: 32.1] [Reference Citation Analysis]
150 Bosch W, Poowanawittayakom N, Chaikriangkrai K, Mendez J, Hellinger W, Gonwa T, Krishna M, Pungpapong S. Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy. Transpl Infect Dis 2013;15:E33-9. [DOI: 10.1111/tid.12048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
151 Bodro M, Sabé N, Santín M, Cruzado J, Lladó L, González-costello J, Carratalà J. Clinical Features and Outcomes of Tuberculosis in Solid Organ Transplant Recipients. Transplantation Proceedings 2012;44:2686-9. [DOI: 10.1016/j.transproceed.2012.09.060] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
152 Stucchi R, Boin I, Angerami R, Zanaga L, Ataide E, Udo E. Is Isoniazid Safe for Liver Transplant Candidates With Latent Tuberculosis? Transplantation Proceedings 2012;44:2406-10. [DOI: 10.1016/j.transproceed.2012.07.035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
153 Pérez JL, Ayats J, de Oña M, Pumarola T. The role of the clinical microbiology laboratory in solid organ transplantation programs. Enferm Infecc Microbiol Clin 2012;30 Suppl 2:2-9. [PMID: 22542029 DOI: 10.1016/S0213-005X(12)70076-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
154 Len Ó, Ramos A, Pahissa A. Evaluating the risk of transmission of infection from donor to recipient of a solid organ transplantation. Enferm Infecc Microbiol Clin 2012;30 Suppl 2:19-26. [PMID: 22542031 DOI: 10.1016/S0213-005X(12)70078-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
155 Doblas A, Alcaide F, Benito N, Gurguí M, Torre-Cisneros J. Tuberculosis in solid organ transplant patients. Enferm Infecc Microbiol Clin. 2012;30 Suppl 2:34-39. [PMID: 22542033 DOI: 10.1016/s0213-005x(12)70080-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
156 Kirsch S, Sester M. Tuberculosis in Transplantation: Diagnosis, Prevention, and Treatment. Curr Infect Dis Rep 2012;14:650-7. [DOI: 10.1007/s11908-012-0293-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
157 Morris MI, Daly JS, Blumberg E, Kumar D, Sester M, Schluger N, Kim SH, Schwartz BS, Ison MG, Humar A, Singh N, Michaels M, Orlowski JP, Delmonico F, Pruett T, John GT, Kotton CN. Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant 2012;12:2288-300. [PMID: 22883346 DOI: 10.1111/j.1600-6143.2012.04205.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 9.6] [Reference Citation Analysis]
158 Kim SY, Jung GS, Kim SK, Chang J, Kim MS, Kim YS, Kang YA, Joo DJ. Comparison of the tuberculin skin test and interferon-γ release assay for the diagnosis of latent tuberculosis infection before kidney transplantation. Infection 2013;41:103-10. [DOI: 10.1007/s15010-012-0291-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
159 Vecino R, Santiago B, Baquero-artigao F, López GL, García C, Muñoz G, Prieto G, Martínez A, de José MI, Mejías A. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Pediatric Infectious Disease Journal 2012;31:774-7. [DOI: 10.1097/inf.0b013e3182564ec7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
160 Witt CA, Meyers BF, Hachem RR. Pulmonary infections following lung transplantation. Thorac Surg Clin 2012;22:403-12. [PMID: 22789602 DOI: 10.1016/j.thorsurg.2012.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
161 López-Medrano F, Carratalà J, Cruzado JM, Gutiérrez MJ, Aguado JM. Fever in a kidney transplant recipient: no facts and many interactions. Rev Clin Esp 2012;212:193-7. [PMID: 22402372 DOI: 10.1016/j.rce.2011.12.013] [Reference Citation Analysis]
162 Muñoz P, Fernández NS, Fariñas MC. Epidemiology and risk factors of infections after solid organ transplantation. Enfermedades Infecciosas y Microbiología Clínica 2012;30:10-8. [DOI: 10.1016/s0213-005x(12)70077-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
163 Gavaldà J, Vidal E, Lumbreras C. Infection prevention in solid organ transplantation. Enfermedades Infecciosas y Microbiología Clínica 2012;30:27-33. [DOI: 10.1016/s0213-005x(12)70079-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
164 Miró JM, Blanes M, Norman F, Martín-dávila P. Infections in solid organ transplantation in special situations: HIV-infection and immigration. Enfermedades Infecciosas y Microbiología Clínica 2012;30:76-85. [DOI: 10.1016/s0213-005x(12)70086-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
165 Ha Y, Joo E, Park S, Wi Y, Kang C, Chung D, Joh J, Lee S, Song J, Peck K. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients. Transpl Infect Dis 2012;14:626-34. [DOI: 10.1111/j.1399-3062.2012.00721.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
166 Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, Len O, Rafecas A, Martín-Davila P, Torre-Cisneros J, Salcedo M, Cordero E, Lozano R, Pérez I, Rimola A, Miró JM; OLT-HIV FIPSE Cohort Investigators. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transpl 2012;18:70-81. [PMID: 21898772 DOI: 10.1002/lt.22431] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
167 Pérez JL, Ayats J, Fortún J, de Oña M, Pumarola T. Microbiología del trasplante. Enfermedades Infecciosas y Microbiología Clínica 2011;29:683-90. [DOI: 10.1016/j.eimc.2011.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
168 Tatar E, Gungor O, Firat O, Kircelli F, Arda B, Harman M, Toz H, Hoscoskun C. Differential Diagnosis of an Unusual Pelvic Mass in a Renal Transplant Recipient: Multidrug-Resistant Abdominopelvic Tuberculosis. Renal Failure 2011;33:1040-2. [DOI: 10.3109/0886022x.2011.618921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
169 Imai S, Ito Y, Hirai T, Imai H, Ito I, Maekawa K, Chin K, Ichiyama S, Uemoto S, Mishima M. Clinical features and risk factors of tuberculosis in living-donor liver transplant recipients. Transplant Infectious Disease 2012;14:9-16. [DOI: 10.1111/j.1399-3062.2011.00680.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
170 Nelson CA, Zunt JR. Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clin Infect Dis 2011;53:915-26. [PMID: 21960714 DOI: 10.1093/cid/cir508] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
171 Doblas A, Torre-Cisneros J. The current state of tuberculosis in solid organ transplantation: three principles for optimal management. Am J Transplant 2011;11:1769-70. [PMID: 21749642 DOI: 10.1111/j.1600-6143.2011.03626.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
172 Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, Ison M, Humar A, Padera RF, Lawler LP, Fisher A, Drew RJ, Gould KF, Sole A, Studer S, Munoz P, Singer LG, Hannan M; ISHLT Infectious Diseases Council Working Group on Definitions. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 2011;30:361-74. [PMID: 21419994 DOI: 10.1016/j.healun.2011.01.701] [Cited by in Crossref: 136] [Cited by in F6Publishing: 142] [Article Influence: 11.3] [Reference Citation Analysis]
173 Santín Cerezales M, Navas Elorza E. Tuberculosis in special populations. Enferm Infecc Microbiol Clin 2011;29 Suppl 1:20-5. [PMID: 21420563 DOI: 10.1016/S0213-005X(11)70014-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
174 Rajagopala S, Olithselvan A, Varghese J, Shanmugam N, Rela M. Latent Mycobacterium tuberculosis Infection in Liver Transplant Recipients-Controversies in Current Diagnosis and Management. J Clin Exp Hepatol 2011;1:34-7. [PMID: 25755308 DOI: 10.1016/S0973-6883(11)60120-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
175 Dalla Gasperina D, Tozzi M, Astuti N, Balsamo M, Donati D, Rossi A, Dionigi R, Grossi P. Pulmonary Tuberculosis in an HIV- and Hepatitis C Virus–Coinfected Kidney-Pancreas Transplant Recipient: A Case Report. Transplantation Proceedings 2011;43:1206-9. [DOI: 10.1016/j.transproceed.2011.02.050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
176 Canet E, Dantal J, Blancho G, Hourmant M, Coupel S. Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years. Nephrol Dial Transplant. 2011;26:3773-3778. [PMID: 21467129 DOI: 10.1093/ndt/gfr156] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
177 Wang X, Zhuang J, Xie L, Li M, Lu Y. Isoniazid preventive therapy for postrenal transplant tuberculosis: a systematic review. Reviews in Medical Microbiology 2011;22:5-11. [DOI: 10.1097/mrm.0b013e3283410434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
178 Donataccio D, Bravo PD, Masotto A, Ceola M, Calabrò F, Donataccio M. Liver Transplantation in a Monolung Patient: A Strategy of Sequential Treatments of Multiple Lung Tuberculosis Ca-vitations and Hepatocellular Carcinoma on Hepatitis B Related Virus Cirrhosis. SS 2011;02:257-261. [DOI: 10.4236/ss.2011.25057] [Reference Citation Analysis]
179 Luong M, Morrissey O, Husain S. Assessment of infection risks prior to lung transplantation: . Current Opinion in Infectious Diseases 2010;23:578-83. [DOI: 10.1097/qco.0b013e32833f9f93] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
180 Yehia BR, Blumberg EA. Mycobacterium tuberculosis infection in liver transplantation. Liver Transpl 2010;16:1129-35. [PMID: 20879011 DOI: 10.1002/lt.22133] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
181 Adamu B, Abdu A, Abba AA, Borodo MM, Tleyjeh IM. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis. Cochrane Database of Systematic Reviews 2010. [DOI: 10.1002/14651858.cd008597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Muñoz P, Valerio M, Palomo J, Fernández-yáñez J, Fernández-cruz A, Guinea J, Bouza E. Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients. Medicine 2010;89:166-75. [DOI: 10.1097/md.0b013e3181dfa59c] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
183 Fortún J, Martín-dávila P, Rodríguez J, Navas E, Moreno S. Infección por Mycobacterium tuberculosis. Medicine - Programa de Formación Médica Continuada Acreditado 2010;10:3808-3819. [DOI: 10.1016/s0304-5412(10)70119-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Kim S, Lee S, Park I, Park S, Choi S, Kim Y, Woo J, Park S, Park J, Kim S, Han D. Diagnostic usefulness of a  T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transplant Infectious Disease 2010;12:113-9. [DOI: 10.1111/j.1399-3062.2010.00495.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
185 Lopez de Castilla D, Schluger N. Tuberculosis following solid organ transplantation. Transplant Infectious Disease 2010;12:106-12. [DOI: 10.1111/j.1399-3062.2009.00475.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 5.8] [Reference Citation Analysis]
186 Holty JE, Sista RR. Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis. Curr Opin Organ Transplant. 2009;14:613-618. [PMID: 19741533 DOI: 10.1097/mot.0b013e3283324dfc] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
187 Muñoz P, Giannella M, Michaels MG, Bouza E. Heart, lung and heart–lung transplantation. Infectious Diseases 2010. [DOI: 10.1016/b978-0-323-04579-7.00076-9] [Reference Citation Analysis]
188 Subramanian A, Dorman S; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009;9 Suppl 4:S57-62. [PMID: 20070696 DOI: 10.1111/j.1600-6143.2009.02894.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 6.2] [Reference Citation Analysis]